This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). Horizon CME is accredited by the ACCME to provide continuing medical education for physicians.
Horizon CME designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
HOW TO CLAIM CREDIT
By reviewing the course content and successfully completing the post-test and evaluation, physicians are entitled to receive 0.75 AMA PRA Category 1 Credits™. A statement of credit will be available to print from your user history page.
LEARNER ASSURANCE STATEMENT
Horizon CME requires all planners, faculty, and other contributors to disclose any financial relationships with an ACCME defined ineligible company within the past 24 months and Horizon CME has resolved any conflicts prior to this educational activity..
Robert Sidbury, MD, MPH
Advisory Boards: Leo Pharma
Contracted Research: Regeneron, Galderma, Pfizer, and Castle.
Steven Feldman, MD, PhD
Consultant: Abbvie, Janssen, Alvotech, vTv, BMS, Samsung, Pfizer, Boehringer, Dermavant, Arcutis, Novartis, UCB, Helsinn, Sun, Almirall, Leo, Mylan, Forte, Arena, Biocon, Accordant, Argenx, and Sanofi.
Speaker: Lilly, Abbvie, Janssen, Alvotech, Amgen, Sun, Sanofi, and Regeneron.
Research Funding: Lilly Abbvie, janssen, Pfizer, UCB, Almirall, and Galderma.
Those involved in the planning of this activity disclosed no financial relationships with an ACCME defined ineligible company within the past 24 months.
Other Contributor DisclosuresAll other non-faculty contributors and others involved in the planning, development and editing/review of the content disclosed no financial relationships with an ACCME defined ineligible company within the past 24 months.
Disclosure of Unlabeled Use
Horizon CME requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
Statement of Independence
Per ACCME, AMA and FDA regulations, it is understood that commercial supporters will have no influence on the content of the activity. Horizon CME will ensure an unbiased presentation and provide full disclosure of relationships between Horizon CME and all commercial supporters and any significant financial interest or other relationship between faculty and manufacturers of commercial products discussed in the activities. It is understood that commercial support funding of this activity is not in any way conditioned upon any present or future business relationship.
This activity is supported by an independent education grant from Sanofi Genzyme and Regeneron Pharmaceuticals.
Copyright © 2022 by Horizon CME. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from Horizon CME.
COURSE VIEWING REQUIREMENTS
|Supported Browsers: |
Internet Explorer 8.0+ for Windows 2000, 2003, Vista, XP, Windows 7, Windows 8
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6+ for Mac OSX 10.7 and above
For video playback, install the latest version of Flash or Quicktime.
|Supported Phones & Tablets: |
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above